Ann M. Hanly, Chief Technology Officer at Vir Biotechnology, Inc. (VIR), bought 11 shares at $43.39 ($500) on 2021-11-29, disclosed to the SEC on 2021-12-01.
Open-market purchase of $500 VIR by Chief Technology Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| VIR | SELL | 2024-02-26 | $247K | — | Filing → |
| VIR | SELL | 2023-03-31 | $120K | — | Filing → |
| VIR | SELL | 2023-02-24 | $120K | — | Filing → |